ResMed (BSP:R1MD34) Asset Impairment Charge : R$0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is ResMed Asset Impairment Charge?

ResMed's Asset Impairment Charge for the three months ended in Mar. 2025 was R$0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

ResMed Asset Impairment Charge Historical Data

The historical data trend for ResMed's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Asset Impairment Charge Chart

ResMed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Asset Impairment Charge

Get a 7-Day Free Trial

75.33

ResMed Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

ResMed Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

ResMed Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of ResMed's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMD:Mexico 0KW4:UK RME:Germany RMEA:Germany RME:Germany RMD:Australia RMD:Austria

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed Headlines

No Headlines